Chemotherapy in non-small cell lung cancer: An update of an individual patient data-based meta-analysis [13] (multiple letters)

Journal of Thoracic and Cardiovascular Surgery

Volumn 129, Issue 5, 2005, Pages 1205-1206

  Burdett, Sarah ^a   Stewart, Lesley ^a   Pignon, Jean Pierre ^b   Sedrakyan, Artyom ^c,d,e   O'Byrne, Ken ^f  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; PLATINUM DERIVATIVE; TEGAFUR; URACIL;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HEART INFARCTION; HUMAN; LETTER; LITERATURE; LUNG NON SMALL CELL CANCER; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; SYSTEMATIC REVIEW; VALIDATION PROCESS;

EID: 18244390213     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.12.032     Document Type: Letter

References (10)

1. M.J. Clarke L.A. Stewart Obtaining individual patient data from randomized controlled trials M. Egger G.D. Smith D. Altman Systematic reviews in health care, meta analysis in context 2001 BMJ Publishing Group London, UK 109 121
2. D.J. Cook G.H. Guyatt G. Ryan Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 269 1993 2749 2753
3. A. Sedrakyan J. Van Der Meulen K. O’Byrne J. Prendiville J. Hill T. Treasure Postoperative chemotherapy for non-small cell lung cancer a systematic review and meta-analysis J Thorac Cardiovasc Surg 128 2004 414 419
4. C. Hamada M. Ohta H. Wada Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small cell lung cancer Proc Am Soc Clin Oncol. 22 2004 abstract 70023.
5. T.L. Winton R. Livingston D. Johnson A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) intergroup JBR.10 J Clin Oncol 22 14S 2004 7018
6. G.M. Strauss J. Herndon M.A. Maddaus Randomised clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC) report of cancer and leukemia group B (CALGB) protocol 9633 J Clin Oncol 22 14S 2004 7019
7. E.M. Antman J. Lau B. Kupelnick F. Mosteller T.C. Chalmers A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts JAMA 268 1992 240 248
8. J. Lau E.M. Antman J. Jimenez-Silva B. Kupelnick F. Mosteller T.C. Chalmers Cumulative meta-analysis of therapeutic trials for myocardial infarction N Engl J Med 327 1992 248 254
9. D.J. Murphy G.J. Povar L.G. Pawlson Setting limits in clinical medicine Arch Intern Med 154 1994 505 512 Review
10. S.D. Halpern J.H. Karlawish J.A. Berlin The continuing unethical conduct of underpowered clinical trials JAMA 288 2002 358 362